Skip to main content

Advertisement

We're creating a new version of this page. See preview

  • Research article
  • Open Access

CXCL8(3–72) K11R/G31P protects against sepsis-induced acute kidney injury via NF-κB and JAK2/STAT3 pathway

Biological Research201952:29

https://doi.org/10.1186/s40659-019-0236-5

©  The Author(s) 2019

  • Received: 17 February 2019
  • Accepted: 25 April 2019
  • Published:

Abstract

Background

Acute kidney injury (AKI), which is mainly caused by sepsis, has high morbidity and mortality rates. CXCL8(3–72) K11R/G31P (G31P) can exert therapeutic effect on inflammatory diseases and malignancies. We aimed to investigate the effect and mechanism of G31P on septic AKI.

Methods

An AKI mouse model was established, and kidney injury was assessed by histological analysis. The contents of serum creatinine (SCr) and blood urea nitrogen (BUN) were measured by commercial kits, whereas neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) were detected by enzyme-linked immunosorbent assay (ELISA) kits. The expressions of CXCL8 in serum and kidney tissues were determined using ELISA and immunohistochemical analysis, respectively. Apoptosis rate of renal tissue was detected by terminal deoxynucleotidyl transfer-mediated dUTP nick end labeling (TUNEL) analysis. The expressions of inflammatory cytokines were measured by quantitative real-time PCR and Western blot, respectively. The apoptosis-related proteins, JAK2, STAT3, NF-κB and IκB were determined by Western blot.

Results

G31P could reduce the levels of SCr, BUN, HGAL and KIM-1 and inhibit the renal tissue injury in AKI mice. G31P was also found to suppress the serum and nephric CXCL8 expressions and attenuated the apoptosis rate. The levels of inflammatory cytokines, pro-apoptotic proteins were decreased, while the anti-apoptotic proteins were increased by G31P in AKI mice. G31P also inhibited the activation of JAK2, STAT3 and NF-κB in AKI mice.

Conclusion

These results suggest that G31P could protect renal function and attenuate the septic AKI. Our findings provide a potential target for the treatment of AKI.

Keywords

  • G31P
  • AKI
  • Inflammation
  • NF-κB
  • JAK2
  • STAT3

Background

Acute kidney injury (AKI), which is one of the severe complications induced by sepsis, is the most excessive systemic inflammatory response [1–3]. Though studies on kidney function have achieved a significant progress, the mechanisms of AKI still remain unclear and the mortality of septic patients is increasing [4]. Furthermore, AKI is demonstrated to be resulted from various factors including dysfunction and apoptosis of renal cells, intrarenal hemodynamic alterations and inflammatory infiltration in the kidney [5], among which renal apoptosis and inflammation are revealed to be critical causes to sepsis-derived AKI [6]. Recently, it has been reported that the pathogenesis of septic AKI was associated with inflammatory signaling pathways in addition to innate immunity [6]. As a crucial factor for health and diseases, apoptosis is proved to be able to cause kidney dysfunction in sepsis-induced AKI [7]. Moreover, apoptosis-related genes have been demonstrated to play a significant role in AKI and apoptosis was found more frequently in renal biopsies from patients with AKI who died from septic shock than those in controls [8, 9]. Therefore, it is imperative to find new effective therapeutic strategies.

It is shown that stimulated kidneys during sepsis could activate the nuclear factor-kappa B (NF-κB) signaling pathway to generate numerous pro-inflammatory cytokines including interleukin (IL)-6 and tumor necrosis factor-α (TNF-α) [9]. NF-κB, which was reported as a major target in a variety of diseases, plays a crucial role in maintaining the stability of the immune system [10–12]. Additionally, Janus kinase 2 (JAK2)/signal transducer and the activator of transcription 3 (STAT3) pathway are demonstrated to mediate the inflammatory response [13–15]. Furthermore, researches revealed that the JAK2/STAT3 pathway was involved in renal diseases [16–18]. The JAK/STAT signaling pathway is essential for immune and inflammatory responses. Previous study also showed that the expressions of TNF-α and IL-6 were increased by activated JAK/STAT pathway in rat lung tissue with sepsis [19], and that suppressing the JAK/STAT pathway could alleviate organ dysfunction in septic rats [20]. Thus, reducing inflammation by preventing the activation of JAK/STAT signaling pathways may have clinical benefits for patients who suffer from septic shock.

Chemokine (C-X-C motif) ligand 8 (CXCL8/IL-8), which can bind to G-protein coupled receptors (CXCR1 and CXCR2), is a chemokine mainly involved in the recruitment and activation of neutrophils [21]. CXCL8 contributes to the pathologies of angiogenesis, fibrosis, infection, arteriosclerosis, and tumor growth [22–26]. Besides, CXCL8 has been reported to be related to AKI in various diseases among patients [27–30]. CXCL8(3–72) K11R/G31P (G31P), which is a CXCL8 antagonist with a more intimate connection to CXCR1 and CXCR2 than to CXCL8, is reported to suppress the chemotactic responses of neutrophils and inhibit the inflammatory response induced by neutrophils [31]. Moreover, G31P is revealed to attenuate cisplatin-induced nephrotoxicity, mitigate pathological kidney injury and alleviate infiltration of neutrophils in kidney [32]. However, the effect of G31P on the sepsis-induced AKI has been hardly reported, thus, our study aimed to explore the potential role in the sepsis-induced AKI.

Methods

Animals and ethics statement

Male C57BL/6 mice (8-week-old) were provided by The Third Hospital of Nanchang (Nanchang, China). All animals were acclimated for 1 week in a 12-h light/dark metabolic cage at room temperature with free diet and water provided. In our study, all animal experiments were approved by the Institutional Animal Care and Use Committee of The Third Hospital of Nanchang.

Animal model and grouping

Mice were randomized into 5 groups (n = 10) as follows: control group, sham group, CLP group, control plus G31P group, CLP plus G31P group. CLP was performed as previously described [Rittirsch, 2009 #47]. An abdominal incision (1 cm) was made to expose the cecum, which was ligated with a 4-0 silk suture (5 mm) from the base of the ileocecal valve. Next, the cecum was doubly perforated using a 21-gauge needle. A small amount of stool was extracted from both holes, and the cecum was returned to the abdominal. The abdomen was then closed in two layers, followed by a subcutaneous injection of resuscitative normal saline. The mice in CLP group and CLP plus G31P group were administrated intraperitoneally with G31P (Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan) once every 2 days at a dose of 0.5 mg/kg. The vehicle group was treated with PBS, and the sham group received the same operative procedure, except for the colon ligation and puncture. The kidney tissues and blood samples were obtained for further analysis at 6, 12 and 24 h after CLP.

Measurement of serum creatinine (SCr) and blood urea nitrogen (BUN)

The blood was centrifuged (3000 rpm for 10 min at 4 °C) at each time point (6, 12 and 24 h) after CLP. The levels of SCr and BUN, which were important indexes of renal injury, were detected following the protocol (Institute of Jiancheng Bioengineering, Nanjing, China) with an AutoAnalyzer (Roche Diagnostics, Mannheim, Germany).

ELISA of urinary NGAL, KIM-1 and serum CXCL8

The expressions of urinary NGAL and KIM-1 and serum CXCL8 in different groups of mice were detected by corresponding Enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN). The mean absorbance was detected at 450 nm on a microplate reader (Thermo Scientific, Pittsburgh, PA).

Hematoxylin–eosin staining analysis and immunohistochemistry (IHC)

Kidney tissues in each group were fixed in 4% paraformaldehyde and blocked in paraffin. Thereafter, the sections were stained in hematoxylin for 5 min and eosin for 3 min. Images of HE sections were observed under an inverted microscope (Leica, Germany). 5 fields were randomly determined from each section. The kidney damage was evaluated according to the loss of brush borders (0–3), tubular vascularization (0–3) and inflammatory cell infiltration (0–3) [Zhou, 2014 #48]. All sections were independently assessed by an investigator in a blinded manner. IHC was performed as previously described [33]. To be more specific, the sections were washed by PBS and blocked in 3% H2O2 for 10 min. and were then incubated with goat serum for 15 min and washed. Subsequently, the sections were incubated with anti-CXCL8 (1:500, Abcam, Cambridge, UK) overnight at 4 °C followed by being incubated with streptavidin peroxidase-conjugated second antibody (Zhongshan Golden Bridge, Beijing, China) for 1 h at 37 °C. Next, the sections were stained with 3,3′-diaminobenzidine (DAB, Zhongshan Golden Bridge) for 6 min and then rinsed and stained in hematoxylin for 30 s. The sections were dehydrated in gradient alcohol and sealed in neutral resins. The integral optical density (IOD) was calculated with Image Pro plus 6.0 software (Microsoft Media Cybernetics, Bethesda, MD, USA).

Terminal deoxynucleotidyl transfer-mediated dUTP nick end labeling (TUNEL) assay

The sections were incubated at 60 °C for 20 min and were then deparaffinized in xylene twice. Next, the sections were washed in graded series of alcohol and rinsed with PBS. Apoptotic cells were detected according to the protocol of TUNEL kit (Roche, Mannheim, Germany), and apoptotic (TUNEL-positive) cells were quantified under 400× magnification.

RNA extraction, cDNA synthesis and quantitative real-time PCR (qPCR)

Total RNA of renal tissues was isolated using Trizol reagent (Invitrogen, San Diego, CA, USA). To be more specific, renal tissues were homogenized in 700 μL Trizol reagent and then by 300 μL chloroform. The samples were then mixed for 5 min. After centrifugation (12,000g for 15 min at 4 °C), the supernatant was carefully drew into a new tube. An equal volume of isopropyl alcohol was added and incubated at room temperature for 20 min. Following the centrifugation (12,000g at 4 °C for 10 min), the supernatants were removed completely and the precipitate was washed twice by 75% ethanol. Finally, nuclease-free DEPC water was added to elute the RNA, and the concentration and purity were detected by Shimadzu UV-2550 UV–visible spectrophotometer (Suzhou, China). The cDNA was obtained by 1 µg RNA according to the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). In brief, the RNA was incubated with 2× RT master mix containing 10× RT Buffer, 25× dNTP Mix, 10× RT Random Primers and MultiScribe™ Reverse Transcriptase at 25 °C for 10 min, followed by at 37 °C for 2 h and at 85 °C for 5 min. The expressions of IL-1β (forward: 5′-TGC CAC CTT TTG ACA GTG ATG AG-3′ and reverse: 5′-TGA TGT GCT GCT GCG AGA TTT-3′), IL-6 (forward: 5′-AGG ATA CCA CTC CCA ACA GAC C-3′ and reverse: 5′-GCA CAA CTC TTT TCT CAT TTC CAC-3′), TNF-α (forward: 5′-ACT CCA GGC GGT GCC TAT G-3′ and reverse: 5′-GTG AGG GTC TGG GCC ATA GAA-3′) and GAPDH (forward: 5′-GCC TTC CGT GTT CCT ACC C-3′ and reverse: 5′-CAG TGG GCC CTC AGA TGC-3′) were determined in the ABI 7500 real-time quantitative PCR system (Life Technologies, Grand Island, NY) under the following conditions: at 95 °C for 5 min, 40 cycles at 95 °C for 15 s, at 56 °C for 30 s. GAPDH served as an internal reference gene and the data were analyzed by the 2−ΔΔCt method (Table 1).
Table 1

Sequences of primers used for quantitative real-time PCR assays

Genename

Forward (5′–3′)

Reverse (5′–3′)

IL-1β

TGCCACCTTTTGACAGTGATGAG

TGATGTGCTGCTGCGAGATTT

IL-6

AGGATACCACTCCCAACAGACC

GCACAACTCTTTTCTCATTTCCAC

TNF-α

ACTCCAGGCGGTGCCTATG

GTGAGGGTCTGGGCCATAGAA

GAPDH

GCCTTCCGTGTTCCTACCC

CAGTGGGCCCTCAGATGC

Western blot

Renal tissues were washed by PBS and lysed in lysis buffer (Beyotime, Shanghai, China), which were incubated on ice for 30 min and oscillated for 30 s. After being centrifuged at 10,000g for 30 min at 4 °C, the supernatant was collected to measure the protein concentrations using BCA kit (Solarbio, Beijing, China). The proteins separated by the SDS-PAGE were transferred onto polyvinylidene difluoride membranes (GE Healthcare, Little Chalfont, United Kingdom). 1 h after blocking, the membranes were incubated overnight at 4 °C with primary antibodies as follows: Bcl-2 (1:500, ab59348, Abcam), Bax (1:500, ab32503, Abcam), pro-caspase-3 (1:500, ab32499, Abcam), cleaved-caspase-3 (1:500, ab49822, Abcam), JAK2 (1:1000, ab108596, Abcam), p-JAK2 (1:500, ab32101, Abcam), STAT3 (1:1000, ab119352, Abcam), p-STAT3 (1:500, ab76315, Abcam), IL-1β (1:1000, #31202, Cell Signaling Technology, Beverly, MA), IL-6 (1:1000, #12912, Cell Signaling Technology), TNF-α (1:1000, #3707, Cell Signaling Technology), NF-κB (1:1000, #8242, Cell Signaling Technology), IκB (1:1000, #4812, Cell Signaling Technology) and β-actin (1:10,000, #4967, Cell Signaling Technology). The membranes were then incubated with secondary antibodies. The bands were determined by a Molecular Imager VersaDoc MP 5000 System (Bio-Rad, Hercules, CA). The densitometry was determined with a Quantity One (Bio-Rad).

Statistical analysis

Data were expressed as mean ± SD and were assessed by one-way ANOVA, followed by Tukey post hoc tests using Graphpad Prism 5 software (San Diego, CA, USA). A P < 0.05 was considered as a statistically significant difference.

Results

G31P protected renal function and alleviated the kidney injury

The role of G31P in kidney function was identified by the levels of several biomarkers including SCr (Fig. 1a), BUN (Fig. 1b), uric NGAL (Fig. 1c) and KIM-1 (Fig. 1d) at different time points. In CLP group and CLP plus G31P group, the levels of SCr, BUN and KIM-1 at 24 h after CLP were markedly elevated, compared with those at 6 and 12 h after CLP (P < 0.01). Similarly, the content of NGAL in CLP plus G31P group at 24 h after CLP was significantly more than those at 6 and 12 h after CLP (P < 0.05). While in CLP group, the NGAL level at 24 h after CLP had no obvious difference from that at 12 h after CLP. The levels of SCr and BUN were evidently improved 24 h after CLP, while the concentrations of uric NGAL and KIM-1 were went up significantly 6 h after CLP. Nevertheless, the contents of these biomarkers were significantly reduced by G31P, which were consistent with the histological changes (Fig. 1e). Obvious renal tubular changes such as abscission of tubular epithelial cells, glomerular hypertrophy, deprivation of brush border, loss of epithelial cell nuclei, prominent vacuolar transformations, epithelial cell necrosis and shed into tubular lumens were observed in CLP group. Moreover, the histological scores of kidney tissues were high after the CLP, while G31P could partly lower the scores (P < 0.05; Fig. 1f).
Fig. 1
Fig. 1

Effects of G31P on the renal function and kidney injury of mice. The blood samples of mice were harvested at 6, 12 and 24 h after the colon ligation and puncture, respectively. The levels of SCr (a) and BUN (b) were determined by chromatometry with kits while NGAL (c) and KIM-1 (d) were measured by ELISA. e Renal histological changes in mice were observed by H&E staining (magnification ×200). f The histological score of kidney tissue injury was evaluated by a blinded pathologist. ns represented no significant difference; ★★P < 0.01 versus the levels of biomarkers at 6 h in each group; #P < 0.05, ##P < 0.01 versus the levels of biomarkers at 12 h in each group. G31P: CXCL8(3–72) K11R/G31P; SCr: serum creatinine; BUN: blood urea nitrogen; NGAL: neutrophil gelatinase-associated lipocalin; KIM-1: kidney injury molecule-1

G31P reduced the expressions of CXCL8 in renal tissues and serum

The CXCL8 expression was significantly up-regulated by CLP and was inhibited by G31P in kidney tissues (Fig. 2a). We also found that the absorbance of CXCL8 in serum was similar to that in the tissues (P < 0.05; Fig. 2b), and that G31P evidently decreased the serum CXCL8 levels by approximately 25% (P < 0.05; Fig. 2c).
Fig. 2
Fig. 2

Effects of G31P on CXCL8 expression in mice. a The CXCL8 expression in renal tissues of mice in 5 groups was measured by immunohistochemistry (magnification ×400). The mean absorbance of serum CXCL8 (b) and the serum CXCL8 expression of mice in 5 groups (c) were determined by ELISA at 24 h after the colon ligation and puncture. ns represented no significant difference

G31P inhibited the apoptosis rate in renal tissues

To determine the effect of G31P on apoptosis in septic AKI, the apoptotic cells of the kidney tissues were detected in the mice. The apoptotic cells were expressed as brown nucleus and apoptotic cells were found more in CLP group than those in sham group (Fig. 3a). Additionally, the apoptosis rate after CLP was increased, while G31P suppressed the apoptosis rate (P < 0.05; Fig. 3b).
Fig. 3
Fig. 3

Effects of G31P on apoptosis of renal cells in mice. a The apoptotic cells (with brown nucleus) were detected by TUNEL analysis (magnification ×400) in 5 groups. b The related apoptosis rate of renal cells of the whole kidney. ns represented no significant difference

G31P exerted anti-inflammatory and anti-apoptotic effects in renal tissues

Chemokines and cytokines are involved in the progression of sepsis-derived AKI [4], thus, we measured the expressions of several pro-inflammatory cytokines in kidney tissues at protein (Fig. 4a) and mRNA levels (Fig. 4b). The expressions of IL-1β, IL-6 and TNF-α were remarkably raised after CLP but were noticeably suppressed by G31P in renal tissues of mice (P < 0.05). Interestingly, the expression of TNF-α in the cntl group plus G31P was significantly reduced, however, the mechanism was unclear.
Fig. 4
Fig. 4

Effects of G31P on pro-inflammatory cytokines and apoptosis-related molecules of kidney in mice. a, b The protein and mRNA levels of IL-1β, IL-6 and TNF-α in 5 groups were determined by western blot and qPCR, respectively. c, d The expression of pro-caspase-3, cleaved-caspase-3, Bcl-2 and Bax of mice in 5 groups were detected by western blot. ns represented no significant difference

Besides, the levels of apoptosis-related proteins in the kidney were determined (Fig. 4c). The biomarkers of advancing apoptosis, pro-caspase-3 and cleaved-caspase-3 were measured. We found that the pro-caspase-3 level was decreased, while cleaved-caspase-3 expression was elevated in the kidney of CLP mice (P < 0.05). However, G31P reversed such an expression pattern (Fig. 4c). Another hallmarks of cell apoptosis, Bcl-2 (anti-apoptosis) and Bax (pro-apoptosis) were also detected in the renal tissues (Fig. 4d). Decreased Bcl-2 expression and increased Bax level were found in the kidney of mice with CLP, however, the expression patterns were partly reversed by G31P (P < 0.05). Moreover, G31P inhibited the Bax levels of mice in the cntl plus G31P (P < 0.05).

G31P suppressed the activation of JAK2 and STAT3

To investigate the effect of G31P on the phosphorylation of JAK2 and STAT, the protein levels of p-JAK2, JAK2, p-STAT3 and STAT3 were determined. The CLP treatment evidently increased the expression of p-JAK2, which was significantly abated by G31P (P < 0.05; Fig. 5a). Similarly, the level of p-STAT3 was markedly induced in the CLP mice but was also reduced by G31P (P < 0.05; Fig. 5b).
Fig. 5
Fig. 5

Effects of G31P on the expression of JAK2 and STAT3 in mice. a The protein levels of p-JAK2 and JAK2 in 5 groups were measured by western blot. b The protein expression of p-STAT3 and STAT3 of mice in 5 groups were measured by western blot. ns represented no significant difference

G31P prevented the activation of NF-κB

To explore the potential roles of G31P in the septic AKI, we detected the levels of renal NF-κB and IκB in mice (Fig. 6a). Though NF-κB expression was evidently higher in the CLP mice than that in sham group, its expression was suppressed by G31P (P < 0.05; Fig. 6b). Also, the decreased protein expression of IκB in CLP mice was recovered by G31P (P < 0.05; Fig. 6c).
Fig. 6
Fig. 6

Effects of G31P on the expression of NF-κB. a–c The protein levels of NF-κB and IκB of mice in 5 groups were detected by Western blot. ns represents no significant difference

Discussion

As septic AKI has high morbidity and mortality [34], it is imperative to find effective therapeutic strategies for treating septic AKI. In the current study, we successfully established a sepsis-induced AKI mouse model. We found that G31P could protect renal function and attenuate the AKI by inhibiting the inflammation and apoptosis. Moreover, the JAK2/STAT3 and NF-κB signaling pathway might be involved in sepsis-induced AKI.

The SCr and BUN are biomarkers of renal dysfunction [35]. Additionally, many protein products have been found as novel markers such as NGAL and KIM-1 in the initial stage of AKI [36–38]. KIM-1 is difficult to be detected in healthy kidneys, however, it is highly expressed in proximal tubule cells after ischemic and nephrotoxic injury [39]. NGAL is shown to have a prognostic value in predicting acute and chronic nephropathies and deterioration of renal function in patients [40]. In our study, the levels of KIM-1 and NGAL were increased sharply 6 h after CLP and such an increase took place earlier than those of SCr and BUN, suggesting that these two biomarkers could ponder renal injury more accurately and faster than SCr and BUN [41]. Furthermore, G31P could reduce the levels of these biomarkers, which was in accordance with the histopathological alterations, indicating that G31P could improve the renal function and alleviate the kidney injury.

Pro-inflammatory cytokines can play a critical role in the later systematic inflammation response and subsequently multi-organ failure in sepsis [42]. CXCL8 is reported to recruit leukocytes from the blood into tissues during inflammation [43] and in turn, the inflammation deteriorated by activated leukocytes could increase CXCL8 level [44]. In the present study, the CXCL8 expressions in serum and kidney were up-regulated obviously in the CLP mice and were reduced by G31P, indicating that G31P might be involved in the inflammatory circle between inflammatory cells and chemokines. Furthermore, the CXCL8, which is a vital chemokine to trigger the local infiltration during renal inflammation, could be regulated by IL-1β and TNF-α [34]. Several pro-inflammatory cytokines have been demonstrated to play a critical role in septic AKI and other systemic dysfunctions in sepsis [45, 46]. Our results showed that G31P decreased the levels of IL-1β, IL-6 and TNF-α in the CLP mice, which was consistent with the results of the previous study on the role of G31P in the HFD/STZ-induced diabetic mice [44].

The apoptosis of renal tubular cells is another crucial pathogenesis of AKI [47]. In the current study, TUNEL analysis revealed that renal tubular cell apoptosis was increased after CLP, and this could be confirmed by the expressions of apoptosis-related proteins. Procaspase-3 can be activated by cleaving, and cleaved caspase-3 can lead to cell death [48]. Bcl-2 is an anti-apoptotic protein, while Bax exerts an opposite effect [49]. In our study, apoptosis was induced by increased expressions of cleaved-caspase-3 and Bax and reduced levels of pro-caspase-3 and Bcl-2 in CLP mice, which were reversed by G31P. These results demonstrated that G31P could inhibit the apoptosis in septic mice.

The activation of JAK2/STAT3 signaling is reported to be involved in the apoptosis and inflammation [50]. It has been reported that JAK2/STAT3 could induce mitochondrial mediated apoptosis [51] and regulate Bax expression in the ischemia reperfusion (IR) injury [52]. Recently, the JAK2/STAT3 signaling pathway has also been confirmed to play a crucial role in inflammatory responses [53, 54]. Furthermore, JAK2 and STAT3 can release of IL-1β, IL-6 and TNF-α and are involved in the inflammatory response, septic shock and acute organ injury [19, 55]. In our study, we found that the levels of phosphorylated JAK2 and STAT3 were enhanced after CLP. G31P could suppress the phosphorylation of JAK2 and STAT3 in CLP mice, suggesting that the JAK2/STAT3 pathway might be related to the anti-apoptotic and anti-inflammatory properties of G31P.

NF-κB is believed as an upstream regulator of inflammation to regulate numerous inflammatory factors. Once activated, NF-κB can deteriorate tissue injury by increasing several inflammatory cytokines [56]. The NF-κB signaling pathway can be activated by TNF-α and can aggravate the inflammatory response in AKI [57, 58], and the inhibition of NF-κB activity can attenuate septic AKI [59]. NF-κB can be released by phosphorylated IκB (inhibitory protein), and released NF-κB is phosphorylated and translocated into the nucleus to mediate the targets [60]. In the present study, an increased level of NF-κB and a decreased IκB expression were observed in the CLP mice. Additionally, the activation of NF-κB was suggested to be positively correlated to apoptosis [61]. Furthermore, the expression of caspase-3 is regulated by NF-κB in kidney tissues from septic patients [47]. In our study, the high level of NF-κB was inhibited, while the decreased IκB expression was improved by G31P in CLP mice, suggesting that G31P might also inhibit the activation of NF-κB, therefore exerting the anti-inflammatory and anti-apoptotic effects in mice.

Conclusion

In conclusion, we have demonstrated that G31P could maintain the renal function and alleviate the sepsis-induced AKI by its anti-inflammatory and anti-apoptotic effects. Also, G31P can inhibit the phosphorylation of JAK2 and STAT3 and inactivate NF-κB after CLP. These results provide a potential therapeutic strategy for septic AKI.

Declarations

Acknowledgements

None.

Funding

None.

Authors’ contributions

Substantial contributions to conception and design: YZ, WX. Data acquisition, data analysis and interpretation: HZ, YZ. Drafting the article or critically revising it for important intellectual content: HZ, WX. Final approval of the version to be published: All authors. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of the work are appropriately investigated and resolved: WX, HZ. All authors read and approved the final manuscript.

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Intensive Medicine, The Third Hospital of Nanchang, Nanchang, Jiangxi, China
(2)
Department of Intensive Medicine, Ruian People’s Hospital, No. 108 Wansong Road, Yuhai Street, Ruian, Wenzhou, 325200, Zhejiang, China

References

  1. Doi K, Noiri E, Maedamamiya R, Ishii T, Negishi K, Hamasaki Y, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med. 2010;38(10):2037–42.PubMedGoogle Scholar
  2. Leelahavanichkul A, Huang Y, Hu X, Zhou H, Tsuji T, Chen R, et al. Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1. Kidney Int. 2011;80(11):1198–211.PubMedPubMed CentralGoogle Scholar
  3. Gomez H, Ince C, De BD, Pickkers P, Payen D, Hotchkiss J, et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014;41(1):3–11.PubMedPubMed CentralGoogle Scholar
  4. Liu J, Abdelrazek O, Liu Z, Hu F, Zhou Q, Cooney RN, et al. Role of surfactant proteins A and D in sepsis-induced acute kidney injury. Shock. 2015;43(1):31–8.PubMedPubMed CentralGoogle Scholar
  5. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock. 2005;24(Suppl 1):52.PubMedGoogle Scholar
  6. Kaushal GP. Autophagy protects proximal tubular cells from injury and apoptosis. Kidney Int. 2012;82(12):1250–3.PubMedPubMed CentralGoogle Scholar
  7. Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, et al. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med. 2012;40(11):2997–3006.PubMedGoogle Scholar
  8. Frank AJ, Sheu CC, Zhao Y, Chen F, Su L, Gong MN, et al. BCL2 genetic variants are associated with acute kidney injury in septic shock. Crit Care Med. 2012;40(7):2116–23.PubMedPubMed CentralGoogle Scholar
  9. Lerolle N, Guerot NE, Bruneval P, Fagon JY, Diehl JL, Hill G. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med. 2010;36(3):471–8.PubMedGoogle Scholar
  10. Biasi F, Leonarduzzi G, Oteiza PI, Poli G. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19(14):1711–47.PubMedPubMed CentralGoogle Scholar
  11. Souza AC, Volpini RA, Shimizu MH, Sanches TR, Camara NO, Semedo P, et al. Erythropoietin prevents sepsis-related acute kidney injury in rats by inhibiting NF-κB and upregulating endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 2012;302(8):F1045.PubMedGoogle Scholar
  12. Sadik NA, Mohamed WA, Ahmed MI. The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis. Mol Cell Biochem. 2012;359(1–2):73–81.PubMedGoogle Scholar
  13. Yu Q, Zeng K, Ma X, Song F, Jiang Y, Tu P, et al. Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways. Int Immunopharmacol. 2016;38:104–14.PubMedGoogle Scholar
  14. Cho SO, Lim JW, Kim H. Red ginseng extract inhibits the expression of MCP-1 and iNOS in Helicobacter pylori-infected gastric epithelial cells by suppressing the activation of NADPH oxidase and Jak2/Stat3. J Ethnopharmacol. 2013;150(2):761–4.PubMedGoogle Scholar
  15. Guo D, Li J-R, Wang Y, Lei L-S, Yu C-L, Chen N-N. Cyclovirobuxinum D suppresses lipopolysaccharide-induced inflammatory responses in murine macrophages in vitro by blocking JAK-STAT signaling pathway. Acta Pharmacol Sin. 2014;35(6):770–8.PubMedPubMed CentralGoogle Scholar
  16. Horiguchi A, Asano T, Kuroda K, Sato A, Asakuma J, Ito K, et al. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma. Br J Cancer. 2010;102(11):1592–9.PubMedPubMed CentralGoogle Scholar
  17. Brands MW, Banes-Berceli AK, Inscho EW, Al-Azawi H, Allen AJ, Labazi H. Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension. 2010;56(5):879.PubMedPubMed CentralGoogle Scholar
  18. Pang M, Ma L, Gong R, Tolbert E, Mao H, Ponnusamy M, et al. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010;78(3):257–68.PubMedGoogle Scholar
  19. Zhang M, Wang X, Wang X, Hou X, Teng P, Jiang Y, et al. Oxymatrine protects against myocardial injury via inhibition of JAK2/STAT3 signaling in rat septic shock. Mol Med Rep. 2013;7(4):1293–9.PubMedGoogle Scholar
  20. Matsukawa A. STAT proteins in innate immunity during sepsis: lessons from gene knockout mice. Acta Med Okayama. 2007;61(5):239.PubMedGoogle Scholar
  21. Yan W, Li F, Qin Y, Ren Y, Zheng L, Dai X, et al. Evaluation of recombinant CXCL8(3-73)K11R/G31P in muscle fibrosis and Trichinella larvae encapsulation in a murine model of trichinellosis. Int Immunopharmacol. 2016;35:323.PubMedGoogle Scholar
  22. Kormann MS, Hector A, Marcos V, Mays LE, Kappler M, Illig T, et al. CXCR22 and CXCR22 haplotypes synergistically modulate cystic fibrosis lung disease. Eur Respir J. 2012;39(6):1385–90.PubMedGoogle Scholar
  23. Pozzobon T, Facchinello N, Bossi F, Capitani N, Benagiano M, Benedetto GD, et al. Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway. Sci Rep. 2016;6:46945.Google Scholar
  24. Qin YH, Fan FS, Zhao Y, Cui Y, Wei XQ, Kohama K, et al. Recombinant human CXCL8(3-72)K11R/G31P regulates smooth muscle cell proliferation and migration through blockage of interleukin-8 receptor. IUBMB Life. 2013;65(1):67–75.PubMedGoogle Scholar
  25. Nagarkar DR, Wang Q, Shim J, Zhao Y, Tsai WC, Lukacs NW, et al. CXCR25 is required for neutrophilic airways inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J Immunol. 2009;183(10):6698–707.PubMedPubMed CentralGoogle Scholar
  26. Chen L, Fan J, Chen H, Meng Z, Chen Z, Wang P, et al. The IL-8/CXCR26 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases. Sci Rep. 2014;4:5911.PubMedPubMed CentralGoogle Scholar
  27. Liu D, Huang P, Li X, Ge M, Luo G, Hei Z. Using inflammatory and oxidative biomarkers in urine to predict early acute kidney injury in patients undergoing liver transplantation. Biomarkers. 2014;19(5):424–9.PubMedGoogle Scholar
  28. Sirota JC, Walcher A, Faubel S, Jani A, Mcfann K, Devarajan P, et al. Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation. BMC Nephrol. 2013;14(1):17.PubMedPubMed CentralGoogle Scholar
  29. de Pablo R, Monserrat J, Prieto A, Alvarez-Mon M. Role of circulating soluble chemokines in septic shock. Med Intensiva. 2013;37(8):510–8.PubMedGoogle Scholar
  30. Liu KD, Glidden DV, Eisner MD, Parsons PE, Ware LB, Wheeler A, et al. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med. 2007;35(12):2755–61.PubMedPubMed CentralGoogle Scholar
  31. Li F, Zhang X, Mizzi C, Gordon JR. CXCL8 (3-73) K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo. Vet Immunol Immunopathol. 2002;90(1–2):65.PubMedGoogle Scholar
  32. Li L, Khan MN, Li Q, Chen X, Wei J, Wang B, et al. G31P, CXCR32/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high-dose cisplatin-induced nephrotoxicity. Oncol Rep. 2015;33(2):751–7.PubMedGoogle Scholar
  33. Zhao X, Town JR, Li F, Zhang X, Cockcroft DW, Gordon JR. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol. 2009;182(5):3213.PubMedGoogle Scholar
  34. Yu C, Qi D, Sun JF, Li P, Fan HY. Rhein prevents endotoxin-induced acute kidney injury by inhibiting NF-κB activities. Sci Rep. 2015;5:11822.PubMedPubMed CentralGoogle Scholar
  35. Hu J, Liu J. Licochalcone A attenuates lipopolysaccharide-induced acute kidney injury by inhibiting NF-κB activation. Inflammation. 2016;39(2):569–74.PubMedGoogle Scholar
  36. Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol. 2010;28(5):486–94.PubMedGoogle Scholar
  37. Gardiner L, Akintola A, Chen G, Catania JM, Vaidya V, Burghardt RC, et al. Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease. Am J Nephrol. 2012;35(2):152–63.PubMedPubMed CentralGoogle Scholar
  38. Sinha V, Vence LM, Salahudeen AK. Urinary tubular protein-based biomarkers in the rodent model of cisplatin nephrotoxicity: a comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney injury. J Investig Med. 2013;61(3):564–8.PubMedGoogle Scholar
  39. Guo L, Takino T, Endo Y, Domoto T, Sato H. Shedding of kidney injury molecule-1 by membrane-type 1 matrix metalloproteinase. J Biochem. 2012;152(5):425–32.PubMedGoogle Scholar
  40. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008;52(3):595.PubMedGoogle Scholar
  41. Luo QH, Chen ML, Chen ZL, Huang C, Cheng AC, Fang J, et al. Evaluation of KIM-1 and NGAL as early indicators for assessment of gentamycin-induced nephrotoxicity in vivo and in vitro. Kidney Blood Press Res. 2016;41(6):911.PubMedGoogle Scholar
  42. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol. 2006;177(3):1967.PubMedGoogle Scholar
  43. Cunha TM, Barsante MM, Guerrero AT, Verri WA, Ferreira SH, Coelho FM, et al. Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR43/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br J Pharmacol. 2008;154(2):460–70.PubMedPubMed CentralGoogle Scholar
  44. Cui S, Zhu Y, Du J, Khan MN, Wang B, Wei J, et al. CXCL8 antagonist improves diabetic nephropathy in male mice with diabetes and attenuates high glucose-induced mesangial injury. Endocrinology. 2017;158(6):1671.PubMedGoogle Scholar
  45. Dirkes S. Sepsis and inflammation: impact on acute kidney injury. Nephrol Nurs J. 2013;40(2):125.PubMedGoogle Scholar
  46. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol. 2002;168(11):5817–23.PubMedGoogle Scholar
  47. Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int. 2011;80(1):29–40.PubMedPubMed CentralGoogle Scholar
  48. Arbo BD, Andrade S, Osterkamp G, Gomez R, Ribeiro MF. Effect of low doses of progesterone in the expression of the GABA(A) receptor α4 subunit and procaspase-3 in the hypothalamus of female rats. Endocrine. 2014;46(3):561–7.PubMedGoogle Scholar
  49. Zhang Y, Jiang Q, Wang N, Dai B, Chen Y, He L. Effects of taspine on proliferation and apoptosis by regulating caspase-3 expression and the ratio of Bax/Bcl-2 in A431 cells. Phytother Res. 2015;25(3):357–64.Google Scholar
  50. Liu Z, Lu G, Zhou Z, Wei J, Chao S. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte. Immunobiology. 2015;220(8):947–53.PubMedGoogle Scholar
  51. Yang Y, Duan W, Jin Z, Yi W, Yan J, Zhang S, et al. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J Pineal Res. 2014;55(3):275–86.Google Scholar
  52. Jiang X, Guo CX, Zeng XJ, Li HH, Chen BX, Du FH. A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathway. Apoptosis. 2015;20(8):1033–47.PubMedGoogle Scholar
  53. Meares GP, Liu Y, Rajbhandari R, Qin H, Nozell SE, Mobley JA, et al. PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation. Mol Cell Biol. 2014;34(20):3911.PubMedPubMed CentralGoogle Scholar
  54. Ma C, Wang Y, Dong L, Li M, Cai W. Anti-inflammatory effect of resveratrol through the suppression of NF-κB and JAK/STAT signaling pathways. Acta Biochim Biophys Sin. 2015;47(3):207–13.PubMedGoogle Scholar
  55. Xi-Bing GU, Yang XJ, Hua Z, Zhong-Hua LU, Zhang B, Zhu YF, et al. Effect of oxymatrine on specific cytotoxic T lymphocyte surface programmed death receptor-1 expression in patients with chronic hepatitis B. Chin Med J. 2012;125(8):1434.Google Scholar
  56. Zhang Y, Fan H, Xu J, Xiao Y, Xu Y, Li Y, et al. Network analysis reveals functional cross-links between disease and inflammation genes. Sci Rep. 2013;3(7478):3426.PubMedPubMed CentralGoogle Scholar
  57. Sanchezniño MD, Benitomartin A, Gonçalves S, Sanz AB, Ucero AC, Izquierdo MC, et al. TNF superfamily: a growing saga of kidney injury modulators. Mediat Inflamm. 2010;2010(4):984–9.Google Scholar
  58. Covert MW, Baltimore D. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science. 2005;309(5742):1854–7.PubMedGoogle Scholar
  59. Höcherl K, Schmidt C, Kurt B, Bucher M. Inhibition of NF-κB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo. Am J Physiol Renal Physiol. 2010;298(1):F196.PubMedGoogle Scholar
  60. Mitchell S, Vargas J, Hoffmann A. Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med. 2016;8(3):227–41.PubMedGoogle Scholar
  61. Zingarelli B. Nuclear factor-kappaB. Crit Care Med. 2005;33(12 Suppl):414–6.Google Scholar

Copyright

© The Author(s) 2019

Advertisement

Biological Research

ISSN: 0717-6287

Contact us